The Efficacy of Rosuvastatin on the Intervention Treatment of Hypertension

Pan Feng; Shen Yi-cong; Li Zhi-dan

您当前的位置：

首页 >

文章列表页 >

The Efficacy of Rosuvastatin on the Intervention Treatment of Hypertension

更新时间：2021-08-23

- The Efficacy of Rosuvastatin on the Intervention Treatment of Hypertension
- Health Medicine Research and Practice Vol. 12, Issue 1, Pages: 63-65(2015)
- 作者机构：
  
  五邑大学校医院
- 作者简介：
- 基金信息：
- DOI：
  CLC： R541.4
- Published：2015，
扫描看全文
[1]潘峰,沈宜聪,李智丹.瑞舒伐他汀干预治疗高血压的疗效观察[J].保健医学研究与实践,2015,12(01):63-65.

Pan Feng, Shen Yi-cong, Li Zhi-dan. The Efficacy of Rosuvastatin on the Intervention Treatment of Hypertension. [J]. Health Medicine Research and Practice 12(1):63-65(2015)
[1]潘峰,沈宜聪,李智丹.瑞舒伐他汀干预治疗高血压的疗效观察[J].保健医学研究与实践,2015,12(01):63-65. DOI：

Pan Feng, Shen Yi-cong, Li Zhi-dan. The Efficacy of Rosuvastatin on the Intervention Treatment of Hypertension. [J]. Health Medicine Research and Practice 12(1):63-65(2015) DOI：

摘要

目的了解高血压病患者在常规治疗过程中采用瑞舒伐他汀药物干预对血脂、血压的影响。方法将86例高血压病患者随机分为观察组与对照组

对照组45例患者口服厄贝沙坦片150 mg

每日1次。观察组41例患者在对照组基础上

口服瑞舒伐他汀片5 mg

每日1次。服用2周后

2组患者中血压未降至140/90mmHg（1mmHg=0.133kPa）者

在原有基础上

依据患者的实际情况

联合应用另外一种降压药物。经过3个月的治疗后

对比2组患者的血脂、血压变化情况。结果治疗后2组患者的血压及总胆固醇（TC）

甘油三酯（TG）

低密度脂蛋白胆固醇（LDL-C）水平均较治疗前下降

差异有统计学意义（P<0.05）;且治疗后观察组上述指标均低于对照组

差异有统计学意义（P<0.05）。结论在高血压的常规治疗中加入瑞舒伐他汀

可以提高疗效

改善患者血压和血脂水平。

Abstract

Objective To investigate the efficacy of rosuvastatin on blood lipid and blood pressure in hypertensive patients in the conventional treatment.Method 86 cases of patients with hypertension were randomly divided into an observation group with 41 cases and a control group with 45 cases.Patients in the control group were taken oral irbesartan tablets 150 mg

once a day.Those in the observation group were taken oral rosuvastatin 5mg

once a day

on the basis of the control group.After two weeks

patients in both groups whose blood pressure were higher than 140/90mmHg（1 mmHg=0.133kPa）were added another antihypertensive drug according to their actual conditions.The changes of blood lipid and blood pressure in all the patients were compared after three-month treatment.Results After the treatment

levels of blood pressure

total cholesterol（TC）

triglyceride（TG）

low density lipoprotein cholesterol（LDL-C）in both groups were lower than pretreatment

and the differences were statistically significant（P<0.05）;all the indicators from the observation group were lower than the control group and the difference between the two groups was statistically significant（P<0.05）.Conclusion The application of rosuvastatin in the conventional treatment of hypertension can enhance the clinical efficacy and improve levels of blood pressure and blood lipid in patients.

关键词

瑞舒伐他汀厄贝沙坦高血压

Keywords

RosuvastatinIrbesartanhypertension

references

查看原文

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Relationship between body mass index, waist circumference, and hypertension of adults in Tongnan district

Clinical efficacy of sacubitril-valsartan in combination with rosuvastatin in the treatment of acute myocardial infarction

E ffects of community-based chronic disease management based on smart wearable devices and the Internet in the health management of hypertensive patients in the community

Analysis of the current situation of hypertension prevalence and influencing factors in Shapingba District,Chongqing

Effect of adaptive psychological nursing on negative emotion in patients with hypertension complicated with heart failure

Related Author

Long Feng

Hao Zhenqiang

Chen Xuelian

Yang Qiaoling

Wang Tongshan

Liu Cuili

Tao Yang

Zhang Yong

Related Institution

Chongqing Tongnan Center for Disease Control and Prevention

Cardiovascular Department, Puyang Guangci Hospital

School of Public Health and Management, Chongqing Medical University

Nan’an District Center for Disease Control and Prevention

Center for Disease Control and Prevention,Shapingba District

⁰